On June 10, 2025, Ironwood Pharmaceuticals held its Annual Meeting where shareholders elected nine directors, approved executive compensation, and ratified Ernst & Young as auditors for 2025, with significant votes tallied for each action.
AI Assistant
IRONWOOD PHARMACEUTICALS INC
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.